14 Oct 2026 · 11 minNew
CD7 Drives AML Chemoresistance, Europe Sees ADHD Surge, Scientists Tune Chirality with Structured Beams, HKU Med Pilot Boosts Health, and more...
CD7 Protein Identified as Key Driver of Chemoresistance in AML, Redefining Treatment Approaches ADHD Diagnoses Surge in Europe: Improved Awareness Drives Recognition, Not Epidemic Revolutionary Light Control: Scientists Tune Chirality and Spin with Structured Beams HKUMed's Chronic Disease Co-Care Pilot Exceeds Targets, Boosts Health Outcomes in Hong Kong Neutron Star Collision Creates Ghostly 'Gold Factory' in Milky Way To subscribe visit https://www.brief.news . For more updates in your inbox each morning visit www.brief.news . Image credit: BIOENGINEER.ORG










